Elacridar-d4 (Major)
Elacridar-d4 (Major) is the deuterium labeled Elacridar (HY-50879) . Elacridar is an orally active P-glycoprotein (Pgp) and breast cancer resistance protein (BCRP) inhibitor. Elacridar can be used to examine the influence of efflux transporters on agent distribution to brain and the research of cancer[1][2].
Product Specifications
CAS Number
[1189481-51-3]
UNSPSC
12352005
Target
BCRP; Isotope-Labeled Compounds; P-glycoprotein
Related Pathways
Membrane Transporter/Ion Channel; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(NC1=CC=C(C([2H])(C([2H])(N2CCC(C=C(C(OC)=C3)OC)=C3C2)[2H])[2H])C=C1)C4=CC=CC5=C4NC6=C(C5=O)C=CC=C6OC
Molecular Formula
C34H29D4N3O5
Molecular Weight
567.67
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
